Spatial heterogeneity in drug concentrations can facilitate the emergence of resistance to cancer therapy.
Acquired resistance is one of the major barriers to successful cancer therapy. The development of resistance is commonly attributed to genetic heterogeneity. However, heterogeneity of drug penetration of the tumor microenvironment both on the microscopic level within solid tumors as well as on the m...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-03-01
|
Series: | PLoS Computational Biology |
Online Access: | http://europepmc.org/articles/PMC4366398?pdf=render |